Division of Infectious Diseases, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
University of Missouri Kansas City School of Medicine, Kansas City, Missouri.
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1396-1402. doi: 10.1017/ice.2021.416. Epub 2021 Oct 22.
To assess current resources, interventions, and obstacles of pediatric outpatient antimicrobial stewardship programs (ASP).
Cross-sectional study.
Institutions from the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient collaborative (SHARPS-OP).
Antimicrobial stewardship leaders from the above institutions.
An investigator-developed survey was deployed online in September 2020 to antimicrobial stewardship leaders in SHARPS-OP institutions. The survey was divided into 4 sections: (1) basic information, (2) status of pediatric outpatient ASP in the institutions including financial support, (3) outpatient ASP interventions undertaken by the institutions, and (4) needs and SHARPS-OP collaborative goals.
Of 56 invited institutions, 45 participated, achieving an 80% response rate. Only 5 sites (11%) had allocated financial support for an outpatient ASP, compared to 42 (95.6%) for their inpatient ASP. The most widely used outpatient ASP interventions included antimicrobial guidance (57.8%), education (46.7%), and quality improvement projects (37.8%). Time was identified as the biggest barrier to expanding outpatient ASPs (91.1%), followed by financial support (53.3%), development of meaningful reports (51.1%), and administrative support (44.4%). Important goals of the collaborative included seeking learning opportunities and developing clear metrics for pediatric outpatient ASP benchmarking. Program needs included securing operational support (35.8%) and strengthening data analysis (31.6%).
Very few pediatric institutions with robust inpatient ASPs have devoted time and financial support to advance outpatient efforts. To promote appropriate antibiotic prescribing in the outpatient arena, time and resource funding by administrative leaders are necessary to develop a robust, sustainable stewardship infrastructure.
评估儿科门诊抗菌药物管理计划(ASP)的现有资源、干预措施和障碍。
横断面研究。
来自共享儿科门诊抗菌药物管理合作(SHARPS-OP)的机构。
来自上述机构的抗菌药物管理负责人。
2020 年 9 月,研究者开发了一项在线调查,向 SHARPS-OP 机构的抗菌药物管理负责人进行调查。该调查分为 4 个部分:(1)基本信息,(2)机构中儿科门诊 ASP 的现状,包括财务支持,(3)机构开展的门诊 ASP 干预措施,以及(4)需求和 SHARPS-OP 合作目标。
在 56 家受邀机构中,有 45 家参与,应答率为 80%。只有 5 家(11%)为门诊 ASP 分配了财务支持,而 42 家(95.6%)为住院 ASP 分配了财务支持。使用最广泛的门诊 ASP 干预措施包括抗菌药物指南(57.8%)、教育(46.7%)和质量改进项目(37.8%)。扩大门诊 ASP 的最大障碍是时间(91.1%),其次是财务支持(53.3%)、有意义的报告制定(51.1%)和行政支持(44.4%)。合作的重要目标包括寻求学习机会和制定儿科门诊 ASP 基准的明确指标。项目需求包括获得运营支持(35.8%)和加强数据分析(31.6%)。
很少有拥有强大住院 ASP 的儿科机构投入时间和资金来推进门诊工作。为了在门诊领域促进适当的抗生素处方,行政领导需要投入时间和资源来建立一个强大、可持续的管理基础设施。